Latest News
Eurofins Viracor introduces BKV inSIGHT T-cell immunity panel for BK virus immune monitoring in kidney transplant patients
23 July 2026 - Diagnostic specialist Eurofins Viracor, a subsidiary of product testing provider Eurofins Scientific (Euronext Paris:ERF), announced on Wednesday the commercial availability of the BKV inSIGHT T-Cell Immunity Panel (TCIP) (Test Code 33...
Nona Biosciences agrees research collaboration with Medical University of Vienna to advance fully human antibody development for infectious diseases
23 July 2026 - Global biotechnology company Nona Biosciences, a wholly owned subsidiary of HBM Holding Limited (HKEX:02142), announced on Wednesday a research collaboration with the Medical University of Vienna (MedUni Vienna).The collaboration enabl...
Ascletis to discuss ASC36_35 FDC preclinical weight loss data at EASD annual meeting
23 July 2026 - Biotechnology company Ascletis Pharma Inc (HKEX:1672) announced on Wednesday that preclinical data of ASC36_35 FDC, a once-monthly injection co-formulation of ASC36, a peptide amylin receptor agonist, and ASC35, a peptide GLP-1R/GIPR a...
GSK's Jideytro (zidesamtinib) gains US approval for previously treated ROS1-positive NSCLC
23 July 2026 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) announced on Wednesday that the US Food and Drug Administration (FDA) has approved Jideytro (zidesamtinib), a ROS1 selective inhibitor, for the treatment of adult patients with loc...
Greenwich LifeSciences secures UK approval to expand Phase III breast cancer trial
22 July 2026 - US biopharmaceutical company Greenwich LifeSciences, Inc. (NASDAQ: GLSI) said on Wednesday it has received regulatory clearance to extend its Phase III FLAMINGO-01 trial into the United Kingdom, enabling the addition of 5–10 UK s...